This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Lucy Chard
9 Jul 2024

Esteve invests €100 million in new manufacturing plant in Spain

Esteve team. Source: [1]

Spain-headquartered CMO Esteve expands its manufacutring capacity in plants in Girona, Spain to increase global API offerings with advanced technological solutions, through a weighty investment of €100 million. 

Esteve is a leading healthcare company and pharmaceutical innovator and partner based in Spain. 

Esteve has a global presence, mostly throughout Europe, but with industrial sites in China and Mexico. In Spain, Esteve has a chemical R&D centre in Barcelona, and three production plants in the Catalan region, located in Celrà (Gironès), Banyeres del Penedès (Baix Penedès), and Lliçà de Vall (Vallès Oriental). Now, they have plans to further increase manufacturing capacity in the region.  

Esteve has initiated a project to construct a new manufacturing unit at its Celrà plant in Girona, with plans to invest €100 million through to 2026. The expansion aims to boost the production capacity of active pharmaceutical ingredients at its primary industrial site. Once the new facilities become operational in the latter quarter of 2026, the company will welcome approximately 100 new employees to its existing team of 370 professionals. The expansion includes building new production and service facilities and installing up to 150 m3 of reaction volume, leading to a 45% increase in Esteve's production capacity at Celrà and a 15% increase in the overall global capacity of the company.

The new unit in Girona illustrates the dedication to advancements in developing, manufacturing, and sales of APIs for CMOs. The latest technological solutions, including in digitalisation and data analysis, incorporated into the facility will ensure the efficient production of highly-potent APIs. 

The facility enables the production of new products to be added to Esteve’s portfolio, which will be distributed throughout the USA, Europe, and Japan. 

"Thanks to our commitment to quality, efficiency and reliability, our activity in the development and manufacturing of active pharmaceutical ingredients has experienced notable growth in recent years. The expansion of our main industrial centre will allow us to satisfy a growing global demand and expand our activity, advancing our mission of improving people's lives", commented Pere Mañé, the General Manager of Esteve Química.

Source:

[1] Esteve Química. Esteve will invest 100 million euros in the construction of a new plant at its industrial centre in Celrà (Girona). [Date accessed 09/07/2024] www.esteve.com/global/news/esteve-will-invest-100-million-euros-in-the-construction-of-a-new-plant-at-its-industrial-centre-in-celra-girona 

Mentioned Companies
Esteve Quimica S.A.
View company profile
Lucy Chard
Digital Editor - Pharma

Related News